EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Observation of a Possible Successful Treatment of DEPDC5-Related Epilepsy with mTOR Inhibitor

Kinga Hadzsiev, Márta Hegyi, András Fogarasi, Tímea Bodó-Baltavári, Anna Zsigmond, Anita Maász, András Szabó, Ágnes Till iD

Neuropediatrics · 2023-10 · 54 (05) · 344-346

DOI: 10.1055/a-2104-1614 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Neuropediatrics, online erschienen am 30.07.2023. Verfasst von Kinga Hadzsiev und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Genetics, Medical School, Clinical Center, University of Pécs, Pécs, Hungary. Hauptthemen laut MEDLINE: Epilepsy, Epilepsies, Partial, Epilepsy, Generalized. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Medical School of University of Pécs, "ÁOK-KA" Research Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The mechanistic target of the rapamycin signaling pathway serves as a central regulator of cell metabolism, growth, proliferation, and survival. In its regulation, the GTPase-activating protein activity toward Rags1 complex has an inhibitory effect. Mutations in genes encoding this complex protein are among the most common abnormalities in focal epilepsies. Within these mutations, the mutations affecting the DEPDC5 gene have been associated with different autosomal dominantly inherited epilepsy types. Due to the limited data available on mTOR inhibitor therapy in nontuberous sclerosis complex epileptic patients, here we present the clinical management of a patient with intractable epilepsy, skin hypopigmentation, and a DEPDC5 variant. The patient's phenotype is compatible with a nonlesional DEPDC5-related epileptic encephalopathy. We initiated compassionate, off-label everolimus treatment as the patient's condition continuously deteriorated. Due to bilateral pneumonia occurring at the beginning of the treatment, it was temporarily discontinued, and resumed in half the dose. Follow-up examination after 18 months showed a 90% reduction in seizure frequency with moderate improvement in attention function and nutritional status. Our case report emphasizes the importance of early genetic testing in patients with epileptic encephalopathy. Clinical consequences of mammalian target of rapamycin complex 1 (mTORC1) upregulation may be amenable to tailored treatment with mTOR inhibitors. A clinical trial on an international scale would be needed to draw conclusions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EpilepsyEpilepsies, PartialEpilepsy, GeneralizedHumansMTOR InhibitorsTOR Serine-Threonine KinasesSeizuresGTPase-Activating Proteins

Substanzen

MTOR InhibitorsTOR Serine-Threonine KinasesDEPDC5 protein, humanGTPase-Activating Proteins

Autor:innen und Institutionen

  • Department of Medical Genetics, Medical School, Clinical Center, University of Pécs, Pécs, Hungary.
  • Bethesda Children's Hospital, Epilepsy Center, Budapest, Hungary.

ORCID-Profile: Ágnes Till

Förderung

  • Medical School of University of Pécs, "ÁOK-KA" Research Program

Zitieren

APA

Hadzsiev, K., Hegyi, M., Fogarasi, A., Bodó-Baltavári, T., Zsigmond, A., Maász, A., Szabó, A., & Till, Á. (2023). Observation of a Possible Successful Treatment of DEPDC5-Related Epilepsy with mTOR Inhibitor. Neuropediatrics, 54(05), 344-346. https://doi.org/10.1055/a-2104-1614

Vancouver

Hadzsiev K, Hegyi M, Fogarasi A, Bodó-Baltavári T, Zsigmond A, Maász A, et al. Observation of a Possible Successful Treatment of DEPDC5-Related Epilepsy with mTOR Inhibitor. Neuropediatrics. 2023;54(05):344-346. doi:10.1055/a-2104-1614

BibTeX
@article{Hadzsiev2023,
  author = {Hadzsiev, Kinga and Hegyi, Márta and Fogarasi, András and Bodó-Baltavári, Tímea and Zsigmond, Anna and Maász, Anita and Szabó, András and Till, Ágnes},
  title = {Observation of a Possible Successful Treatment of DEPDC5-Related Epilepsy with mTOR Inhibitor},
  journal = {Neuropediatrics},
  year = {2023},
  volume = {54},
  number = {05},
  pages = {344--346},
  doi = {10.1055/a-2104-1614}
}
Kostenlos starten →